Innovative Ultrasound Technique Validated for Noninvasive Central Venous Pressure Measurement
A groundbreaking study validates a noninvasive ultrasound method to accurately measure central venous pressure, offering a safer alternative to invasive procedures and improving patient management in cardiovascular care.
A recent clinical pilot study has demonstrated the effectiveness of a novel noninvasive method to measure central venous pressure (CVP) using quantitative compression ultrasound (QCU). Conducted by researchers from the Massachusetts Institute of Technology (MIT) and Massachusetts General Hospital (MGH), this advancement offers a promising alternative to traditional invasive techniques, which often involve risks and require significant resources.
The study enrolled 11 patients from MGH's cardiac intensive care unit, all with standard central venous catheters. Researchers captured QCU data, including high-resolution ultrasound images of the internal jugular vein (IJV), while simultaneously recording the force applied to the skin surface. These measurements were then compared to the gold-standard invasive CVP readings obtained directly from the catheters. In addition, jugular venous pulsation height (JVP), a common noninvasive clinical measurement, was assessed in some patients for comparison.
Results showed a strong correlation between the force needed to fully occlude the IJV, known as the collapse force (CF), and invasive CVP measurements. Statistical analysis revealed an r² value of 0.82, with a mean absolute error just over 1 mmHg. When accounting for hydrostatic pressure, the correlation slightly improved to 0.83. Conversely, JVP showed a weaker correlation with CVP, with an r² of 0.45.
The implications of these findings are significant for clinical practice. Accurate and noninvasive CVP assessment can enhance patient management in conditions like heart failure and sepsis, where CVP guides treatment decisions. Compared to invasive methods, QCU reduces risk, discomfort, and resource utilization, and surpasses traditional methods like JVP in reliability.
Led by experts from MIT and Harvard Medical School, including Alex T. Jaffe, Roger Pallarès-López, Jeffrey K. Raines, and Aaron D. Aguirre, this research paves the way for broader application of ultrasound technology in patient care. The study underscores the potential of QCU to transform circulatory assessment by enabling more frequent, safe, and precise monitoring, particularly in settings constrained by resources.
Source: https://medicalxpress.com/news/2025-05-noninvasive-ultrasound-method-central-venous.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Study Reveals Lung Damage Is Not the Primary Cause of Persistent Infections in Cystic Fibrosis
New research shows that lung damage isn't the main reason for persistent bacterial infections in cystic fibrosis, highlighting bacterial adaptation and spread as key factors.
Innovative Nanovesicle Formulation Enhances Cancer Drug Delivery and Efficacy
A newly developed nanovesicle formulation of paclitaxel improves targeted delivery to tumors, reduces side effects, and enhances the efficacy of combination cancer therapies, paving the way for advanced treatment options.
GERD and Its Potential Link to Ear Disorders Including Tinnitus and Meniere Disease
Emerging evidence links Gastroesophageal Reflux Disease (GERD) to increased risks of ear disorders such as tinnitus, Meniere disease, and hearing loss. New research highlights the potential causal relationship and its implications for ear health management.
Innovative Rapid and Comfort-Driven Breast Imaging Technology Shows Promise in Early Clinical Trials
A new rapid, pain-free breast imaging system combining photoacoustic and ultrasound technologies shows great potential in early clinical testing, promising improved detection and patient comfort for breast cancer screening.